Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perforation of a malignant ovarian tumor into the recto-sigmoid colon.
Bats AS, Rockall AG, Singh N, Reznek RH, Jeyarajah A. Bats AS, et al. Among authors: jeyarajah a. Acta Obstet Gynecol Scand. 2010 Oct;89(10):1362-3. doi: 10.3109/00016349.2010.501857. Acta Obstet Gynecol Scand. 2010. PMID: 20726830 Free article.
Cytoreductive surgery in ovarian cancer.
Pomel C, Jeyarajah A, Oram D, Shepherd J, Milliken D, Dauplat J, Reynolds K. Pomel C, et al. Among authors: jeyarajah a. Cancer Imaging. 2007 Dec 17;7(1):210-5. doi: 10.1102/1470-7330.2007.0030. Cancer Imaging. 2007. PMID: 18083650 Free PMC article. Review.
Vulval cancer: what is an adequate surgical margin?
Balega J, Butler J, Jeyarajah A, Oram D, Shepherd J, Faruqi A, Singh N, Reynolds K. Balega J, et al. Among authors: jeyarajah a. Eur J Gynaecol Oncol. 2008;29(5):455-8. Eur J Gynaecol Oncol. 2008. PMID: 19051811
Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.
Böhm S, Faruqi A, Said I, Lockley M, Brockbank E, Jeyarajah A, Fitzpatrick A, Ennis D, Dowe T, Santos JL, Cook LS, Tinker AV, Le ND, Gilks CB, Singh N. Böhm S, et al. Among authors: jeyarajah a. J Clin Oncol. 2015 Aug 1;33(22):2457-63. doi: 10.1200/JCO.2014.60.5212. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124480
Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma.
Böhm S, Montfort A, Pearce OM, Topping J, Chakravarty P, Everitt GL, Clear A, McDermott JR, Ennis D, Dowe T, Fitzpatrick A, Brockbank EC, Lawrence AC, Jeyarajah A, Faruqi AZ, McNeish IA, Singh N, Lockley M, Balkwill FR. Böhm S, et al. Among authors: jeyarajah a. Clin Cancer Res. 2016 Jun 15;22(12):3025-36. doi: 10.1158/1078-0432.CCR-15-2657. Clin Cancer Res. 2016. PMID: 27306793 Free article.
Routine Appendicectomy is Unnecessary in Mucinous Borderline Ovarian Tumors.
Muglu J, Casey L, Rather H, Makhija S, Brockbank E, Kokka F, Faruqi A, Singh N, Jeyarajah A. Muglu J, et al. Among authors: jeyarajah a. Int J Gynecol Pathol. 2018 Jan;37(1):57-58. doi: 10.1097/PGP.0000000000000372. Int J Gynecol Pathol. 2018. PMID: 28319577 No abstract available.
Histopathologic response to neoadjuvant chemotherapy as a prognostic biomarker in tubo-ovarian high-grade serous carcinoma: updated Chemotherapy Response Score (CRS) results.
Böhm S, Le N, Lockley M, Brockbank E, Faruqi A, Said I, Jeyarajah A, Wuntakal R, Gilks B, Singh N. Böhm S, et al. Among authors: jeyarajah a. Int J Gynecol Cancer. 2019 Feb;29(2):353-356. doi: 10.1136/ijgc-2018-000092. Epub 2019 Jan 25. Int J Gynecol Cancer. 2019. PMID: 30683759
52 results